A Low-Cost Modular Imaging System for Rapid, Multiplexed Immunofluorescence Detection in Clinical Tissues.
cutaneous T-cell lymphoma
immunofluorescence
in situ protein detection
multiplex fluorescence imaging
tumor marker profiling
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
10 Apr 2023
10 Apr 2023
Historique:
received:
25
02
2023
revised:
03
04
2023
accepted:
07
04
2023
medline:
1
5
2023
pubmed:
28
4
2023
entrez:
28
4
2023
Statut:
epublish
Résumé
To image 4-plex immunofluorescence-stained tissue samples at a low cost with cellular level resolution and sensitivity and dynamic range required to detect lowly and highly abundant targets, here we describe a robust, inexpensive (<$9000), 3D printable portable imaging device (Tissue Imager). The Tissue Imager can immediately be deployed on benchtops for in situ protein detection in tissue samples. Applications for this device are broad, ranging from answering basic biological questions to clinical pathology, where immunofluorescence can detect a larger number of markers than the standard H&E or chromogenic immunohistochemistry (CIH) staining, while the low cost also allows usage in classrooms. After characterizing our platform's specificity and sensitivity, we demonstrate imaging of a 4-plex immunology panel in human cutaneous T-cell lymphoma (CTCL) formalin-fixed paraffin-embedded (FFPE) tissue samples. From those images, positive cells were detected using CellProfiler, a popular open-source software package, for tumor marker profiling. We achieved a performance on par with commercial epifluorescence microscopes that are >10 times more expensive than our Tissue Imager. This device enables rapid immunofluorescence detection in tissue sections at a low cost for scientists and clinicians and can provide students with a hands-on experience to understand engineering and instrumentation. We note that for using the Tissue Imager as a medical device in clinical settings, a comprehensive review and approval processes would be required.
Identifiants
pubmed: 37108170
pii: ijms24087008
doi: 10.3390/ijms24087008
pmc: PMC10138925
pii:
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIH HHS
ID : AI060573
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR075047
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA217378
Pays : United States
Organisme : NIGMS NIH HHS
ID : R21 GM135493
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA062203
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI060573
Pays : United States
Organisme : NINDS NIH HHS
ID : T32 NS082174
Pays : United States
Références
Methods Mol Biol. 2017;1554:237-251
pubmed: 28185197
J Am Acad Dermatol. 2000 Nov;43(5 Pt 2):946-54
pubmed: 11044831
Breast Cancer Res. 2021 Jan 7;23(1):2
pubmed: 33413574
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Front Oncol. 2019 Apr 11;9:260
pubmed: 31032224
Oncoimmunology. 2015 Mar 19;4(6):e1008355
pubmed: 26155417
Differentiation. 2000 May;65(5):287-300
pubmed: 10929208
Science. 2018 Mar 23;359(6382):1350-1355
pubmed: 29567705
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Genome Biol. 2006;7(10):R100
pubmed: 17076895
Lab Chip. 2017 Mar 14;17(6):1083-1094
pubmed: 28225099
Cell. 2018 Nov 1;175(4):998-1013.e20
pubmed: 30388456
J Pharm Bioallied Sci. 2012 Aug;4(Suppl 2):S307-9
pubmed: 23066277
Biomed Opt Express. 2017 Oct 19;8(11):5075-5086
pubmed: 29188104
Biotechniques. 2007 Jan;42(1):71-5
pubmed: 17269487
ACS Nano. 2013 Oct 22;7(10):9147-55
pubmed: 24016065
J Surg Oncol. 2018 Jul;118(1):21-30
pubmed: 29878370
J Clin Invest. 2012 Dec;122(12):4439-46
pubmed: 23143304
Nat Rev Genet. 2019 Dec;20(12):724-746
pubmed: 31515541
Methods. 2014 Nov;70(1):46-58
pubmed: 25242720
Methods Mol Biol. 2020;2055:585-592
pubmed: 31502170
J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S78-86
pubmed: 22018071
Sci Rep. 2017 Nov 14;7(1):15580
pubmed: 29138507
Biomed Opt Express. 2020 Apr 08;11(5):2447-2460
pubmed: 32499936
Mol Imaging. 2022 Mar 22;2022:7908357
pubmed: 35418808
Sci Rep. 2020 Oct 15;10(1):17507
pubmed: 33060677
J Immunol. 2016 May 1;196(9):3943-50
pubmed: 26994219
Sci Rep. 2021 Apr 19;11(1):8511
pubmed: 33875760
Nat Biotechnol. 2020 May;38(5):586-599
pubmed: 32393914
Am J Pathol. 1999 Aug;155(2):483-92
pubmed: 10433941
F1000Res. 2016 Jul 28;5:
pubmed: 27540476
Clin Cancer Res. 2019 Sep 15;25(18):5503-5512
pubmed: 31189645
Nat Med. 2018 Nov;24(11):1649-1654
pubmed: 30297909
Expert Rev Mol Diagn. 2010 May;10(4):417-34
pubmed: 20465497
PLoS One. 2009 Jul 22;4(7):e6320
pubmed: 19623251